Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Public ClinicalTrials.gov record NCT06971939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Multicenter, Open-label Study to Evaluate Long-term Safety and Efficacy of Revakinagene Taroretcel-Lwey (NT-501) Previously Implanted During a Phase 1, Phase 2, or Phase 3 Clinical Study and to Evaluate NT-501 Implanted in Participants Who Underwent the Sham Procedure in a Phase 3 Clinical Study of Macular Telangiectasia Type 2 (MacTel)
Study identification
- NCT ID
- NCT06971939
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Neurotech Pharmaceuticals
- Industry
- Enrollment
- 285 participants
Conditions and interventions
Conditions
Interventions
- NT-501/revakinagene taroretcel-lwey Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 20, 2025
- Primary completion
- Jan 14, 2032
- Completion
- Jan 14, 2032
- Last update posted
- Apr 28, 2026
2025 – 2032
United States locations
- U.S. sites
- 24
- U.S. states
- 17
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps Health | La Jolla | California | 92037 | Not yet recruiting |
| Jules Stein Eye Institute/UCLA | Los Angeles | California | 90085 | Not yet recruiting |
| Stanford University School of Medicine | Palo Alto | California | 94303 | Not yet recruiting |
| Bay Area Retina Associates | Walnut Creek | California | 94598 | Recruiting |
| Colorado Retina | Lakewood | Colorado | 80228 | Recruiting |
| Bascom Palmer | Miami | Florida | 33136 | Not yet recruiting |
| Emory Eye Center | Atlanta | Georgia | 30322 | Recruiting |
| Northwestern University | Chicago | Illinois | 60611 | Not yet recruiting |
| National Eye Institute | Bethesda | Maryland | 20892 | Not yet recruiting |
| Cumberland Valley Retina Consultants | Frederick | Maryland | 21702 | Not yet recruiting |
| Massachusetts Eye and Ear Infirmary, Retina Service | Boston | Massachusetts | 02114 | Not yet recruiting |
| Foundation for Vision Research | Grand Rapids | Michigan | 49525 | Recruiting |
| Retina Consultants of Minnesota | Minneapolis | Minnesota | 55435 | Not yet recruiting |
| Envision Ocular, LLC | Bloomfield | New Jersey | 07003 | Recruiting |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45242 | Recruiting |
| Retina Associates of Cleveland, Inc. | Cleveland | Ohio | 44126 | Recruiting |
| Tulsa Retina Consultants | Tulsa | Oklahoma | 74132 | Not yet recruiting |
| Retina Northwest, P.C. | Portland | Oregon | 97221 | Not yet recruiting |
| Scheie Eye Institute | Philadelphia | Pennsylvania | 19104 | Not yet recruiting |
| Southeastern Retina Associates, P.C. | Knoxville | Tennessee | 37922 | Recruiting |
| Texas Retina Associates | Dallas | Texas | 75231 | Not yet recruiting |
| Retina Center of Texas | Dallas | Texas | 75251 | Recruiting |
| Retina Consultants of Texas | Houston | Texas | 77030 | Recruiting |
| University of Utah John A. Moran Center | Salt Lake City | Utah | 84132 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06971939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06971939 live on ClinicalTrials.gov.